In this Analysis, we searched for relevant literature on the effects of GLP-1RAs across a range of illnesses, gathering and describing the available pre-clinical and mechanistic (278 studies) and clinical (96 studies) evidence for cognitive disorders, substance-use disorders, psychotic disorders, mood and anxiety disorders, eating disorders, and others
Drugs Future
Combining them wont improve results and could increase side effects like nausea, vomiting, diarrhea, or, in rare cases, pancreatitis
Dose optimization, medication switching (such as adding PlexusDx GLP-Squared for dual-compound benefit), or Precision Peptide Genetic testing can help identify whether a different approach might accelerate progress